REG - Haleon PLC - Transactions in Own Shares

Haleon PLC announced the purchase of 11,006,678 shares as part of its share buyback program. The company's registered share capital is now 8,808,341,409 shares, with 39,812,973 held as treasury shares. The number of voting shares is 8,768,528,436. Details of the trades are available on the company's website.

Original reporting
Published Nov 16, 2026, 7:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 9:56 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
REG - Haleon PLC - Transactions in Own Shares — source image
Decision brief

The 30-second read

$HLNBullishMed
01

Why it matters

The announcement could provide short‑term price support but the modest scale limits broader market effect.

02

Market read

A routine buyback tranche with modest size; likely modest upside for HLN.

03

What to watch

The tranche size is small relative to total float; impact may be muted if market already priced in buyback expectations.

Relevance 6/10Novelty 6/10Timing: after-market today

Background

Haleon (LSE/NYSE: HLN) disclosed a new share repurchase of 11 million shares, raising its treasury holdings to 39.8 million shares.

Company-level read

Ticker impact

$HLNBullishHigh confidence
Context

Haleon announced the purchase of 11,006,678 shares for its treasury buyback programme, increasing its treasury holdings.

Expected impact

likely upward pressure as investors view the buyback as a supportive move

Evidence & confidence

Buybacks typically lift share price, especially when announced as a fresh tranche; the size is modest but adds to existing treasury holdings.

Market effects

Limited; reinforces confidence in consumer health sector but no broader impact.

Minor effect on UK and US markets where Haleon trades.

Low; isolated to Haleon shareholders.

Counterpoint

Buybacks may signal lack of growth opportunities, suggesting caution.

Key entities

  • Haleon plc

    Consumer health company listed in London and New York.

Related articles

$HLNHigh

Haleon margin reset and weak sales beyond oral care prompt Jefferies downgrade to 'hold'

Haleon PLC (HLN) was downgraded to 'hold' by Jefferies, which cited weak sales outside oral health and cut its price target 20% to 320p. Haleon guided to 2.5% organic sales growth, down from 4%, and Q3 growth missed consensus. Jefferies expects a 150-basis-point margin reduction by 2027 and cut its 2027 EPS forecast 11% to 19.9p. Shares trade at their lowest valuation since mid-2022.

$HLNMed

Deutsche Bank upgrades Haleon stock rating on valuation reset

Deutsche Bank upgraded Haleon (NYSE:HLN) to Hold from Sell, lowering its price target to GBP3.10. The stock has fallen 16.6% in a week, near its 52-week low. The firm cited weak growth due to industry changes and poor execution. InvestingPro notes the stock is undervalued. Haleon's Q3 2026 results missed expectations, but it maintained its full-year profit outlook.

$HLNHighAI 8/10

Haleon Sinks 14% on Growth Downgrade Despite £500 Million Buyback: “Q3 Was Below Our Expectations”

Haleon shares fell 14% after lowering its 2026 organic revenue growth outlook to around 2.5% from 3%-5%. The company announced a £500 million buyback, but it failed to offset investor concerns. CEO Brian McNamara stated Q3 results were below expectations, with organic revenue growth at 2.6%, down from 3.1% in Q2. The company's medium-term growth goal remains 4%-6%.

$GOOGLHighAI 8/10

European stocks rally after ECB and Fed holds

European stocks rose on Thursday after the ECB and Fed left interest rates unchanged. The FTSE 100 gained 0.3%, while the CAC 40 and DAX 40 climbed 1.1% and 1.3% respectively. ECB President Christine Lagarde announced her resignation. Alphabet shares fell 12% after missing earnings expectations. Shell reported better-than-expected results, while Haleon cut its revenue guidance.